首页/数据集/Data for: Favorable outcomes with tumor burden reduction following the administration of hypomethylating agents before allogeneic hematopoietic cell transplantation in patients with higher-risk myelodysplastic syndrome

Data for: Favorable outcomes with tumor burden reduction following the administration of hypomethylating agents before allogeneic hematopoietic cell transplantation in patients with higher-risk myelodysplastic syndrome

NIAID Data Ecosystem2026-03-11 收录

骨髓增生异常综合征

异基因造血干细胞移植预后

数据链接：

https://data.mendeley.com/datasets/cn8n65v5gt 数据链接链接失效反馈

官方服务：

资源简介：

This Excel file is the data of the patients we analyzed.

应用场景：

创建时间：

2019-05-03

铜缺乏症

骨髓增生异常综合征

While copper deficiency is rare, it can have serious consequences, including pancytopenia and neuropathy. This treatable vitamin deficiency can present very similarly to myelodysplastic syndrome (MDS)

DataCite Commons2023-07-22 更新80

Data_Sheet_1_Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 Patients.docx

骨髓增生异常综合征

造血干细胞移植

The treatment outcomes of intermediate or high-risk myelodysplastic syndrome (MDS) remain unsatisfactory. This study was designed to evaluate the safety and efficacy of human leukocyte antigen (HLA)-m

NIAID Data Ecosystem40

The average GVL of MDS patients and the discrimination between the high grade MDS and the low grade MDS by both cell morphology and IPSS score.

骨髓增生异常综合征

血液病诊断

A GVL of zero implies that there is no selected abnormal region in the corresponding arrays.

NIAID Data Ecosystem30

General characteristics of the whole MDS population as compared to a reference group with normal serum iron indices and hepcidin.

骨髓增生异常综合征

铁代谢指标

*: geometric means with 95% Confidence Intervals between bracke.

Figshare2015-12-02 更新40

The Bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression [CD34+CD38-_MDS]

骨髓增生异常综合征

骨髓微环境免疫调节

Myelodysplastic syndromes (MDS) are a heterogenous group of diseases affecting the hematopoietic stem cell that are curable only by stem cell transplantation. Both hematopoietic cell intrinsic changes

NIAID Data Ecosystem30

Data for: Favorable outcomes with tumor burden reduction following the administration of hypomethylating agents before allogeneic hematopoietic cell transplantation in patients with higher-risk myelodysplastic syndrome

资源简介：

相关数据集